The PHLDA3 gene helps keep cell growth and survival under control by damping down AKT, a signal that tells cells when to grow and stay alive. If this gene does not work well, cells may divide more than they should or avoid normal cell death. Many variants are harmless, while some that reduce PHLDA3 activity may contribute to tumor development, including certain neuroendocrine tumors. The PHLDA3 gene is mainly known in cancer research rather than through widely shared public stories.
What is a gene?
Genes are stretches of DNA that give cells instructions for making molecules or managing processes throughout the body. Some genes provide the directions for producing proteins, which do much of the cell’s work. Others are used mainly to regulate when certain processes happen, where they happen, and how active they are. As a group, genes affect body development and everyday function, and they can influence how you respond to food, stress, or medications. For a deeper look at this topic, visit the LearnHub.
Overview
PHLDA3Gene function
What if the gene works
The PHLDA3 gene helps keep cell growth and survival signals in balance. Its protein can dampen AKT, a major cell growth signal, supporting normal stress responses and helping cells avoid growing when they should not.
Risk
What if the gene does not work
Variants in the PHLDA3 gene can be milder or more severe and may weaken its control over AKT, a cell growth signal. With less PHLDA3 activity, growth and survival signals can stay active longer than usual.
Treatment
What does that mean for your treatment
No PHLDA3-specific treatment or drug-selection approach is currently established in clinical guidelines for people with a pathogenic or loss-of-function variant in the PHLDA3 gene. The PHLDA3 gene is being studied as a cancer biomarker, especially in pancreatic neuroendocrine tumors, and as part of cell-growth signaling that may inform future targeted treatments.
Gene function
What if the gene works
The PHLDA3 gene helps your cells keep growth and survival signals in check. It is part of a built in response that tones down AKT signaling, a main pathway cells use to manage growth, energy use, and survival. Overall, the PHLDA3 gene function in cell growth control and stress signaling helps cells act in a more balanced way.
The protein made from the PHLDA3 gene helps keep AKT, a major cell growth and survival signal, from becoming too active. It competes for membrane docking spots, which makes it harder for AKT to switch fully on.
The TP53 gene can turn on the PHLDA3 gene when cells need a more measured response to stress. This helps lower signals that push growth at times when cells should pause and reset.
By limiting AKT activity, the PHLDA3 gene supports normal balance between growth, energy use, and survival cues. This helps many cells respond in a controlled, steady way during normal daily function.
What is a variant?
A genetic variant is a slight difference in the DNA sequence within a gene. These differences are common and help shape normal human diversity, including variation in appearance, metabolism, and how the body responds to environmental influences. Many do not lead to any noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant can change gene function more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the PHLDA3 gene often alter the shape or stability of the protein, which can weaken its ability to attach to membrane lipids and hold back AKT, a cell growth signal. Some variants in the PHLDA3 gene have a mild effect, while more severe variants can sharply reduce protein production or create a shortened protein that is cleared quickly. How variants affect the PHLDA3 gene depends on how much they lower this braking effect inside cells.
How variants are linked to conditions
The PHLDA3 gene does not yet have a broadly confirmed link to a specific health condition, though this can change as research develops. Current evidence on how PHLDA3 gene variants are linked to conditions is still evolving, so a finding in this gene usually needs careful interpretation in the context of your personal and family history. Anyone with a confirmed PHLDA3-related diagnosis should rely on guidance from their doctor or genetic counselor rather than general information.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not directly affect health and simply reflect natural differences among people. For many genes, having a variant associated with a condition points to a possible link rather than a definite diagnosis, particularly when several genes and environmental influences play a role. In some situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce risk related to the PHLDA3 gene. If a change in PHLDA3 has been found in you or your family, a doctor or genetic counselor can help explain what it may mean for your personal cancer risk.
Inheritance of PHLDA3 variants
There is not yet a broadly confirmed, disease-associated Mendelian inheritance pattern for the PHLDA3 gene, so a clear answer to how PHLDA3 gene variants are inherited is still developing. Current evidence has not established a single well accepted pattern such as autosomal dominant or autosomal recessive for a specific PHLDA3 related condition. The PHLDA3 gene is located on chromosome 1, which is an autosome. That means each person inherits one copy of the PHLDA3 gene from each parent.
What does my PHLDA3 result mean for my family?
There isn't yet a broadly confirmed inheritance pattern tied to a specific health condition for PHLDA3, though this understanding can change as research develops. If you have a specific PHLDA3 result and questions about what it could mean for your family, a doctor or genetic counselor can explain it in the context of your personal and family history.
Genetic information
Genetic testing
How you find out about variants
PHLDA3 genetic testing usually uses a blood or saliva sample, and a lab reads the PHLDA3 gene to look for variants. Results may show a disease linked variant, no relevant variant found, or a variant of uncertain significance, which means the change is not yet clearly understood.
When should I consider getting a genetic test?
There is not yet a broadly established reason to test the PHLDA3 gene on its own. Decisions about genetic testing are usually based on your personal and family history, such as uncommon hormone-related or pancreatic tumors, and are best made with a doctor or genetic counselor.
A genetic result is only one part of your health story
A genetic finding can provide useful insight, but how much it reveals varies by the condition and the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body functions. For some conditions, especially those affected by many genes, genetic information offers context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result can provide a clear answer. In areas such as medication response, genetic information can help make sense of individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Some people break down a drug more quickly, while others process it more slowly or are more sensitive to its effects. This helps explain why the same treatment can work well for one person, cause more side effects in another, or seem less effective in someone else. These differences are common and are one part of why medication response varies from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can affect their response to medicines. It studies gene-drug patterns to understand more clearly why the same treatment may work differently in different people. With many medications, genes can influence both how strongly a medicine works and how the body handles it. This information can support treatment decisions that are more informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the PHLDA3 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medicine choice or dosing. If you have questions about side effects, how well a treatment is working, or how your medicines may interact with your health conditions, talk with your doctor or pharmacist.
History
PHLDA3 entered the research literature in the 2000s, when cancer genetics studies began mapping genes that help control cell growth. Scientists then identified the PHLDA3 gene as a target of the TP53 pathway, a finding that drew interest because TP53 is one of the best known genes in cancer biology. From these first observations, research expanded steadily. In 2010, studies linked loss of PHLDA3 to pancreatic neuroendocrine tumors, which gave the gene a clearer place in tumor research. Since then, PHLDA3 has remained mainly of scientific and clinical interest rather than broad public attention, with its history centered on how cancer researchers uncovered new pathways involved in tumor formation.